The genetic basis of systemic lupus erythematosus: What are the risk factors and what have we learned

Journal of Autoimmunity

Volumn 74, Issue , 2016, Pages 161-175

  Teruel, Maria ^a   Alarcón Riquelme, Marta E ^a,b  

^a UNIVERSITY OF GRANADA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Association studies; Co autoimmunity; Functional variants; Next generation sequencing; Populations; SNPs

Indexed keywords

STAT4 PROTEIN;

ASIAN; BANK 1 GENE; CAUSALITY; DNA MODIFICATION; EPIGENETICS; ETHNICITY; EUROPEAN; GENE; GENE LOCUS; GENE REPLICATION; GENE STRUCTURE; GENETIC RISK; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE ENVIRONMENT INTERACTION; HLA SYSTEM; HUMAN; ITGAM GENE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; CHROMOSOMAL MAPPING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOMICS; IMMUNOLOGY; PROCEDURES; QUANTITATIVE TRAIT LOCUS;

ANIMALS; CHROMOSOME MAPPING; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; QUANTITATIVE TRAIT LOCI; RISK FACTORS;

EID: 84992597814     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2016.08.001     Document Type: Review

References (183)

1. [1] Nived, O., Sturfelt, G., Wollheim, F., Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria. Br. J. Rheumatol. 24 (1985), 147–154.
2. [2] Alarcon-Segovia, D., Alarcon-Riquelme, M.E., Cardiel, M.H., Caeiro, F., Massardo, L., Villa, A.R., et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum. 52 (2005), 1138–1147.
3. [3] Danchenko, N., Satia, J.A., Anthony, M.S., Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15 (2006), 308–318.
4. [4] Ghaussy, N.O., Sibbitt, W. Jr., Bankhurst, A.D., Qualls, C.R., The effect of race on disease activity in systemic lupus erythematosus. J. Rheumatol. 31 (2004), 915–919.
5. [5] Sanchez, E., Rasmussen, A., Riba, L., Acevedo-Vasquez, E., Kelly, J.A., Langefeld, C.D., et al. Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum. 64 (2012), 3687–3694.
6. [6] Seldin, M.F., Qi, L., Scherbarth, H.R., Tian, C., Ransom, M., Silva, G., et al. Amerindian ancestry in Argentina is associated with increased risk for systemic lupus erythematosus. Genes Immun. 9 (2008), 389–393.
7. [7] Uramoto, K.M., Michet, C.J. Jr., Thumboo, J., Sunku, J., O'Fallon, W.M., Gabriel, S.E., Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 42 (1999), 46–50.
8. [8] Walsh, S.J., Algert, C., Gregorio, D.I., Reisine, S.T., Rothfield, N.F., Divergent racial trends in mortality from systemic lupus erythematosus. J. Rheumatol. 22 (1995), 1663–1668.
9. [9] Ivanyi, D., Dostal, C., Mrklas, L., HLA-B8 in systemic lupus erythematosus. Tissue Antigens 8 (1976), 91–93.
10. [10] Kampf, D., Malchus, R., Alexander, M., Hoppe, I., HLA-antigens in systemic lupus erythematosus (SLE). Arch. Dermatol. Res. 264 (1979), 345–350.
11. [11] Scherak, O., Kolarz, G., Mayr, W.R., HLA-B8 in caucasian patients with systemic lupus erythematosus. Scand. J. Rheumatol. 7 (1978), 3–6.
12. [12] Scherak, O., Smolen, J.S., Mayr, W.R., HLA-DRw3 and systemic lupus erythematosus. Arthritis Rheum. 23 (1980), 954–957.
13. [13] Stastny, P., Gilliam, J.N., HLA-A1, B8, DRw3 in patients with a distinct form of lupus erythematosus. Transpl. Proc. 11 (1979), 1869–1870.
14. [14] Salmon, J.E., Millard, S., Schachter, L.A., Arnett, F.C., Ginzler, E.M., Gourley, M.F., et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J. Clin. InvestigInvestig. 97 (1996), 1348–1354.
15. [15] Wu, J., Edberg, J.C., Redecha, P.B., Bansal, V., Guyre, P.M., Coleman, K., et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J. Clin. InvestigInvestig. 100 (1997), 1059–1070.
16. [16] Hatta, Y., Tsuchiya, N., Ohashi, J., Matsushita, M., Fujiwara, K., Hagiwara, K., et al. Association of Fc gamma receptor IIIB, but not of Fc gamma receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese. Genes Immun. 1 (1999), 53–60.
17. [17] Zuniga, R., Ng, S., Peterson, M.G., Reveille, J.D., Baethge, B.A., Alarcon, G.S., et al. Low-binding alleles of Fcgamma receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients. Arthritis Rheum. 44 (2001), 361–367.
18. [18] Begovich, A.B., Carlton, V.E., Honigberg, L.A., Schrodi, S.J., Chokkalingam, A.P., Alexander, H.C., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet., 2004, 75.
19. [19] Kyogoku, C., Langefeld, C.D., Ortmann, W.A., Lee, A., Selby, S., Carlton, V.E., et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 75 (2004), 504–507.
20. [20] Onengut-Gumuscu, S., Ewens, K.G., Spielman, R.S., Concannon, P., A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families. Genes Immun. 5 (2004), 678–680.
21. [21] Remmers, E.F., Plenge, R.M., Lee, A.T., Graham, R.R., Hom, G., Behrens, T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 357 (2007), 977–986.
22. [22] Sigurdsson, S., Nordmark, G., Goring, H.H., Lindroos, K., Wiman, A.C., Sturfelt, G., et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet. 76 (2005), 528–537.
23. [23] Prokunina, L., Castillejo-Lopez, C., Oberg, F., Gunnarsson, I., Berg, L., Magnusson, V., et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32 (2002), 666–669.
24. [24] Velazquez-Cruz, R., Orozco, L., Espinosa-Rosales, F., Carreno-Manjarrez, R., Solis-Vallejo, E., Lopez-Lara, N.D., et al. Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus. Eur. J. Hum. Genet. 15 (2007), 336–341.
25. [25] Dong, H.R., Li, H.S., Wang, S.C., Balin, Q.M., Chang, P.Y., Association between PDCD1, CTLA4, and MECP2 gene polymorphisms and systemic lupus erythematosus in the Chinese Northern Han. Genet. Mol. Res. GMR 14 (2015), 17567–17573.
26. [26] Mahmoudi, M., Rezaiemanesh, A., Salmaninejad, A., Harsini, S., Poursani, S., Bahrami, T., et al. PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus. Autoimmunity 48 (2015), 488–493.
27. [27] Chua, K.H., Lian, L.H., Sim, X.J., Cheah, T.E., Lau, T.P., Association between PDCD1 gene polymorphisms and risk of systemic lupus erythematosus in three main ethnic groups of the Malaysian population. Int. J. Mol. Sci. 16 (2015), 9794–9803.
28. [28] Liu, J.L., Zhang, F.Y., Liang, Y.H., Xiao, F.L., Zhang, S.Q., Cheng, Y.L., et al. Association between the PD1.3A/G polymorphism of the PDCD1 gene and systemic lupus erythematosus in European populations: a meta-analysis. J. Eur. Acad. Dermatol. Venereol. 23 (2009), 425–432.
29. [29] Goldberg, M.A., Arnett, F.C., Bias, W.B., Shulman, L.E., Histocompatibility antigens in systemic lupus erythematosus. Arthritis Rheum. 19 (1976), 129–132.
30. [30] Schur, P.H., Genetics of complement deficiencies associated with lupus-like syndromes. Arthritis Rheum. 21 (1978), S153–S160.
31. [31] Celada, A., Barras, C., Benzonana, G., Jeannet, M., Increased frequency of HLA-DRw3 in systemic lupus erythematosus. N. Engl. J. Med., 301, 1979, 1398.
32. [32] Vandersteen, P.R., Provost, T.T., Jordon, R.E., McDuffie, F.C., C2 deficient systemic lupus erythematosus: its association with anti-Ro (SSA) antibodies. Arch. Dermatol. 118 (1982), 584–587.
33. [33] Christiansen, F.T., Dawkins, R.L., Uko, G., McCluskey, J., Kay, P.H., Zilko, P.J., Complement allotyping in SLE: association with C4A null. Aust. N. Z. J. Med. 13 (1983), 483–488.
34. [34] Whittingham, S., Mackay, I.R., Tait, B.D., Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjogren's syndrome. Aust. N. Z. J. Med. 13 (1983), 565–570.
35. [35] Goldmann, T., Blank, T., Prinz, M., Fine-tuning of type I IFN-signaling in microglia–implications for homeostasis, CNS autoimmunity and interferonopathies. Curr. Opin. Neurobiol. 36 (2016), 38–42.
36. [36] Crow, Y.J., Manel, N., Aicardi-Goutieres syndrome and the type I interferonopathies. Nat. Rev. Immunol. 15 (2015), 429–440.
37. [37] Lee-Kirsch, M.A., Wolf, C., Kretschmer, S., Roers, A., Type I interferonopathies–an expanding disease spectrum of immunodysregulation. Semin. Immunopathol. 37 (2015), 349–357.
38. [38] Crow, Y.J., Type I interferonopathies: mendelian type I interferon up-regulation. Curr. Opin. Immunol. 32 (2015), 7–12.
39. [39] Meyts, I., Casanova, J.L., A human inborn error connects the alpha's. Nat. Immunol. 17 (2016), 472–474.
40. [40] Harley, J.B., Alarcon-Riquelme, M.E., Criswell, L.A., Jacob, C.O., Kimberly, R.P., Moser, K.L., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40 (2008), 204–210.
41. [41] Hom, G., Graham, R.R., Modrek, B., Taylor, K.E., Ortmann, W., Garnier, S., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 358 (2008), 900–909.
42. [42] Crow, M.K., Collaboration, genetic associations, and lupus erythematosus. N. Engl. J. Med. 358 (2008), 956–961.
43. [43] Nath, S.K., Han, S., Kim-Howard, X., Kelly, J.A., Viswanathan, P., Gilkeson, G.S., et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat. Genet. 40 (2008), 152–154.
44. [44] Kozyrev, S.V., Abelson, A.K., Wojcik, J., Zaghlool, A., Linga Reddy, M.V., Sanchez, E., et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat. Genet. 40 (2008), 211–216.
45. [45] Bentham, J., Morris, D.L., Cunninghame Graham, D.S., Pinder, C.L., Tombleson, P., Behrens, T.W., et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47 (2015), 1457–1464.
46. [46] Sawalha, A.H., Webb, R., Han, S., Kelly, J.A., Kaufman, K.M., Kimberly, R.P., et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS ONE, 3, 2008, e1727.
47. [47] Kawagoe, T., Sato, S., Matsushita, K., Kato, H., Matsui, K., Kumagai, Y., et al. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9 (2008), 684–691.
48. [48] Jacob, C.O., Zhu, J., Armstrong, D.L., Yan, M., Han, J., Zhou, X.J., et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 6256–6261.
49. [49] Kaufman, K.M., Zhao, J., Kelly, J.A., Hughes, T., Adler, A., Sanchez, E., et al. Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann. Rheum. Dis. 72 (2013), 437–444.
50. [50] Koelsch, K.A., Webb, R., Jeffries, M., Dozmorov, M.G., Frank, M.B., Guthridge, J.M., et al. Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. J. Autoimmun. 41 (2013), 168–174.
51. [51] Zhang, Y., Zhang, J., Yang, J., Wang, Y., Zhang, L., Zuo, X., et al. Meta-analysis of GWAS on two Chinese populations followed by replication identifies novel genetic variants on the X chromosome associated with systemic lupus erythematosus. Hum. Mol. Genet. 24 (2015), 274–284.
52. [52] Alarcon-Riquelme, M.E., Ziegler, J.T., Molineros, J., Howard, T.D., Moreno-Estrada, A., Sanchez-Rodriguez, E., et al. GWAS in an Amerindian ancestry population reveals novel systemic lupus erythematosus risk loci and the role of European admixture. Arthritis Rheumatol. 68 (2016), 932–943.
53. [53] Liu, K., Kurien, B.T., Zimmerman, S.L., Kaufman, K.M., Taft, D.H., Kottyan, L.C., et al. X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and sjogren's syndrome. Arthritis Rheumatol. 68 (2016), 1290–1300.
54. [54] Dillon, S., Aggarwal, R., Harding, J.W., Li, L.J., Weissman, M.H., Li, S., et al. Klinefelter's syndrome (47,XXY) among men with systemic lupus erythematosus. Acta Paediatr. 100 (2011), 819–823.
55. [55] Han, J.W., Zheng, H.F., Cui, Y., Sun, L.D., Ye, D.Q., Hu, Z., et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41 (2009), 1234–1237.
56. [56] Yang, W., Zhao, M., Hirankarn, N., Lau, C.S., Mok, C.C., Chan, T.M., et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum. Mol. Genet. 18 (2009), 2063–2070.
57. [57] Yang, W., Shen, N., Ye, D.Q., Liu, Q., Zhang, Y., Qian, X.X., et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet., 6, 2010, e1000841.
58. [58] Yang, W., Tang, H., Zhang, Y., Tang, X., Zhang, J., Sun, L., et al. Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. Am. J. Hum. Genet. 92 (2013), 41–51.
59. [59] Lessard, C.J., Adrianto, I., Ice, J.A., Wiley, G.B., Kelly, J.A., Glenn, S.B., et al. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am. J. Hum. Genet. 90 (2012), 648–660.
60. [60] Okada, Y., Shimane, K., Kochi, Y., Tahira, T., Suzuki, A., Higasa, K., et al. A genome-wide association study identified AFF1 as a susceptibility locus for systemic lupus erythematosus in Japanese. PLoS Genet., 8, 2012, e1002455.
61. [61] Wang, C., Ahlford, A., Jarvinen, T.M., Nordmark, G., Eloranta, M.L., Gunnarsson, I., et al. Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eur. J. Hum. Genet. 21 (2013), 994–999.
62. [62] Cen, H., Leng, R.X., Wang, W., Zhou, M., Feng, C.C., Zhu, Y., et al. Association study of IFIH1 rs1990760 polymorphism with systemic lupus erythematosus in a Chinese population. Inflammation 36 (2013), 444–448.
63. [63] Deng, Y., Zhao, J., Sakurai, D., Kaufman, K.M., Edberg, J.C., Kimberly, R.P., et al. MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. PLoS Genet., 9, 2013, e1003336.
64. [64] Manku, H., Langefeld, C.D., Guerra, S.G., Malik, T.H., Alarcon-Riquelme, M., Anaya, J.M., et al. Trans-ancestral studies fine map the SLE-susceptibility locus TNFSF4. PLoS Genet., 9, 2013, e1003554.
65. [65] Martins, M., Williams, A.H., Comeau, M., Marion, M., Ziegler, J.T., Freedman, B.I., et al. Genetic association of CD247 (CD3zeta) with SLE in a large-scale multiethnic study. Genes Immun. 16 (2015), 142–150.
66. [66] Zhang, J., Zhang, L., Zhang, Y., Yang, J., Guo, M., Sun, L., et al. Gene-based meta-analysis of genome-wide association study data identifies independent single-nucleotide polymorphisms in ANXA6 as being associated with systemic lupus erythematosus in Asian populations. Arthritis Rheumatol. 67 (2015), 2966–2977.
67. [67] Caster, D.J., Korte, E.A., Nanda, S.K., McLeish, K.R., Oliver, R.K., G'Sell, R.T., et al. ABIN1 dysfunction as a genetic basis for lupus nephritis. J. Am. Soc. Nephrol. JASN 24 (2013), 1743–1754.
68. [68] Lessard, C.J., Sajuthi, S., Zhao, J., Kim, K., Ice, J.A., Li, H., et al. Identification of a systemic lupus erythematosus risk locus spanning ATG16L2, FCHSD2, and P2RY2 in Koreans. Arthritis Rheumatol. 68 (2016), 1197–1209.
69. [69] Sun, C., Molineros, J.E., Looger, L.L., Zhou, X.J., Kim, K., Okada, Y., et al. High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry. Nat. Genet. 48 (2016), 323–330.
70. [70] Lofgren, S.E., Delgado-Vega, A.M., Gallant, C.J., Sanchez, E., Frostegard, J., Truedsson, L., et al. A 3′-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus. Arthritis Rheum. 62 (2010), 3404–3414.
71. [71] Zheng, X., Shen, J., Cox, C., Wakefield, J.C., Ehm, M.G., Nelson, M.R., et al. HIBAG-HLA genotype imputation with attribute bagging. pharmacogenomics J. 14 (2014), 192–200.
72. [72] Sanchez, E., Comeau, M.E., Freedman, B.I., Kelly, J.A., Kaufman, K.M., Langefeld, C.D., et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum. 63 (2011), 3493–3501.
73. [73] Lessard, C.J., Adrianto, I., Kelly, J.A., Kaufman, K.M., Grundahl, K.M., Adler, A., et al. Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am. J. Hum. Genet. 88 (2011), 83–91.
74. [74] Adrianto, I., Wang, S., Wiley, G.B., Lessard, C.J., Kelly, J.A., Adler, A.J., et al. Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. Arthritis Rheum. 64 (2012), 3695–3705.
75. [75] Molineros, J.E., Maiti, A.K., Sun, C., Looger, L.L., Han, S., Kim-Howard, X., et al. Admixture mapping in lupus identifies multiple functional variants within ifih1 associated with apoptosis, inflammation, and autoantibody production. PLoS Genet., 9, 2013, e1003222.
76. [76] Raj, P., Rai, E., Song, R., Khan, S., Wakeland, B.E., Viswanathan, K., et al. Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity. eLife, 2016, 5.
77. [77] Kozyrev, S.V., Alarcon-Riquelme, M.E., The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 40 (2007), 591–601.
78. [78] Graham, R.R., Kozyrev, S.V., Baechler, E.C., Reddy, M.V., Plenge, R.M., Bauer, J.W., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 38 (2006), 550–555.
79. [79] Cunninghame Graham, D.S., Manku, H., Wagner, S., Reid, J., Timms, K., Gutin, A., et al. Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Hum. Mol. Genet. 16 (2007), 579–591.
80. [80] Graham, R.R., Kyogoku, C., Sigurdsson, S., Vlasova, I.A., Davies, L.R., Baechler, E.C., et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 6758–6763.
81. [81] Sigurdsson, S., Padyukov, L., Kurreeman, F.A., Liljedahl, U., Wiman, A.C., Alfredsson, L., et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum. 56 (2007), 2202–2210.
82. [82] Reddy, M.V., Velazquez-Cruz, R., Baca, V., Lima, G., Granados, J., Orozco, L., et al. Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Hum. Genet. 121 (2007), 721–727.
83. [83] Kottyan, L.C., Zoller, E.E., Bene, J., Lu, X., Kelly, J.A., Rupert, A.M., et al. The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Hum. Mol. Genet. 24 (2015), 582–596.
84. [84] Abelson, A.K., Delgado-Vega, A.M., Kozyrev, S.V., Sanchez, E., Velazquez-Cruz, R., Eriksson, N., et al. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann. Rheum. Dis. 68 (2009), 1746–1753.
85. [85] Namjou, B., Sestak, A.L., Armstrong, D.L., Zidovetzki, R., Kelly, J.A., Jacob, N., et al. High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum. 60 (2009), 1085–1095.
86. [86] Sigurdsson, S., Nordmark, G., Garnier, S., Grundberg, E., Kwan, T., Nilsson, O., et al. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum. Mol. Genet. 17 (2008), 2868–2876.
87. [87] Han, J.W., Zheng, H.F., Cui, Y., Sun, L.D., Ye, D.Q., Hu, Z., et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 41 (2009), 1234–1237.
88. [88] Tsuchiya, N., Kawasaki, A., Hasegawa, M., Fujimoto, M., Takehara, K., Kawaguchi, Y., et al. Association of STAT4 polymorphism with systemic sclerosis in a Japanese population. Ann. Rheum. Dis. 68 (2009), 1375–1376.
89. [89] Bolin, K., Sandling, J.K., Zickert, A., Jonsen, A., Sjowall, C., Svenungsson, E., et al. Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis. PLoS ONE, 8, 2013, e84450.
90. [90] Chung, S.A., Taylor, K.E., Graham, R.R., Nititham, J., Lee, A.T., Ortmann, W.A., et al. Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet., 7, 2011, e1001323.
91. [91] Wu, Y.Y., Kumar, R., Iida, R., Bagavant, H., Alarcon-Riquelme, M.E., BANK1 regulates IgG production in a lupus model by controlling TLR7-dependent STAT1 activation. PLoS One, 11, 2016, e0156302.
92. [92] Rhodes, B., Furnrohr, B.G., Roberts, A.L., Tzircotis, G., Schett, G., Spector, T.D., et al. The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes. Ann. Rheum. Dis. 71 (2012), 2028–2034.
93. [93] MacPherson, M., Lek, H.S., Prescott, A., Fagerholm, S.C., A systemic lupus erythematosus-associated R77H substitution in the CD11b chain of the Mac-1 integrin compromises leukocyte adhesion and phagocytosis. J. Biol. Chem. 286 (2011), 17303–17310.
94. [94] Gateva, V., Sandling, J.K., Hom, G., Taylor, K.E., Chung, S.A., Sun, X., et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41 (2009), 1228–1233.
95. [95] Fernando, M.M.A., Goyettem, P., Oksenberg, J., Behrens, T., Hauser, S.L., Rioux, J.D., et al. Dissecting the MHC contribution to SLE. Ann. Rheum. Dis., 67, 2008, 113.
96. [96] Morris, D.L., Taylor, K.E., Fernando, M.M., Nititham, J., Alarcon-Riquelme, M.E., Barcellos, L.F., et al. Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. Am. J. Hum. Genet. 91 (2012), 778–793.
97. [97] Boteva, L., Morris, D.L., Cortes-Hernandez, J., Martin, J., Vyse, T.J., Fernando, M.M., Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish Populations. Am. J. Hum. Genet. 90 (2012), 445–456.
98. [98] Jansen, R.C., Nap, J.P., Genetical genomics: the added value from segregation. Trends Genet. 17 (2001), 388–391.
99. [99] Manolio, T.A., Collins, F.S., Cox, N.J., Goldstein, D.B., Hindorff, L.A., Hunter, D.J., et al. Finding the missing heritability of complex diseases. Nature 461 (2009), 747–753.
100. [100] Arechiga, A.F., Habib, T., He, Y., Zhang, X., Zhang, Z.Y., Funk, A., et al. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J. Immunol. 182 (2009), 3343–3347.
101. [101] Giltiay, N.V., Chappell, C.P., Clark, E.A., B-cell selection and the development of autoantibodies. Arthritis Res. Ther., 14(Suppl 4), 2012, S1.
102. [102] Menard, L., Saadoun, D., Isnardi, I., Ng, Y.S., Meyers, G., Massad, C., et al. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J. Clin. InvestigInvestig. 121 (2011), 3635–3644.
103. [103] Okada, Y., Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506 (2014), 376–381.
104. [104] Carmona, F.D., Cenit, M.C., Diaz-Gallo, L.M., Broen, J.C., Simeon, C.P., Carreira, P.E., et al. New insight on the Xq28 association with systemic sclerosis. Ann. Rheum. Dis. 72 (2013), 2032–2038.
105. [105] Liu, G., Tsuruta, Y., Gao, Z., Park, Y.J., Abraham, E., Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity. J. Immunol. 179 (2007), 4125–4134.
106. [106] Webb, R., Wren, J.D., Jeffries, M., Kelly, J.A., Kaufman, K.M., Tang, Y., et al. Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis Rheum. 60 (2009), 1076–1084.
107. [107] Dixon, A.L., Liang, L., Moffatt, M.F., Chen, W., Heath, S., Wong, K.C., et al. A genome-wide association study of global gene expression. Nat. Genet. 39 (2007), 1202–1207.
108. [108] Dimas, A.S., Deutsch, S., Stranger, B.E., Montgomery, S.B., Borel, C., Attar-Cohen, H., et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 325 (2009), 1246–1250.
109. [109] Nicolae, D.L., Gamazon, E., Zhang, W., Duan, S., Dolan, M.E., Cox, N.J., Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet., 6, 2010, e1000888.
110. [110] Lalonde, E., Ha, K.C., Wang, Z., Bemmo, A., Kleinman, C.L., Kwan, T., et al. RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression. Genome Res. 21 (2011), 545–554.
111. [111] Majewski, J., Pastinen, T., The study of eQTL variations by RNA-seq: from SNPs to phenotypes. Trends Genet. 27 (2011), 72–79.
112. [112] Westra, H.J., Peters, M.J., Esko, T., Yaghootkar, H., Schurmann, C., Kettunen, J., et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45 (2013), 1238–1243.
113. [113] Javierre, B.M., Fernandez, A.F., Richter, J., Al-Shahrour, F., Martin-Subero, J.I., Rodriguez-Ubreva, J., et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 20 (2010), 170–179.
114. [114] Ceribelli, A., Satoh, M., Chan, E.K., MicroRNAs and autoimmunity. Curr. Opin. Immunol. 24 (2012), 686–691.
115. [115] Chan, E.K., Ceribelli, A., Satoh, M., MicroRNA-146a in autoimmunity and innate immune responses. Ann. Rheum. Dis.(Suppl 2), 2013, 72 ii90-5.
116. [116] Liang, D., Shen, N., MicroRNA involvement in lupus: the beginning of a new tale. Curr. Opin. Rheumatol. 24 (2012), 489–498.
117. [117] Pauley, K.M., Cha, S., Chan, E.K., MicroRNA in autoimmunity and autoimmune diseases. J. Autoimmun. 32 (2009), 189–194.
118. [118] Zhou, X., Jeker, L.T., Fife, B.T., Zhu, S., Anderson, M.S., McManus, M.T., et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205 (2008), 1983–1991.
119. [119] Rasmussen, T.K., Andersen, T., Bak, R.O., Yiu, G., Sorensen, C.M., Stengaard-Pedersen, K., et al. Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus. Arthritis Res. Ther., 17, 2015, 154.
120. [120] Ding, S., Liang, Y., Zhao, M., Liang, G., Long, H., Zhao, S., et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum. 64 (2012), 2953–2963.
121. [121] Zhao, X., Tang, Y., Qu, B., Cui, H., Wang, S., Wang, L., et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 62 (2010), 3425–3435.
122. [122] Fan, W., Liang, D., Tang, Y., Qu, B., Cui, H., Luo, X., et al. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum. 64 (2012), 3715–3725.
123. [123] Pan, W., Zhu, S., Yuan, M., Cui, H., Wang, L., Luo, X., et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 184 (2010), 6773–6781.
124. [124] Zhao, S., Wang, Y., Liang, Y., Zhao, M., Long, H., Ding, S., et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 63 (2011), 1376–1386.
125. [125] Hou, J., Wang, P., Lin, L., Liu, X., Ma, F., An, H., et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183 (2009), 2150–2158.
126. [126] Lofgren, S.E., Frostegard, J., Truedsson, L., Pons-Estel, B.A., D'Alfonso, S., Witte, T., et al. Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. Genes Immun. 13 (2012), 268–274.
127. [127] Tang, Y., Luo, X., Cui, H., Ni, X., Yuan, M., Guo, Y., et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 60 (2009), 1065–1075.
128. [128] Te, J.L., Dozmorov, I.M., Guthridge, J.M., Nguyen, K.L., Cavett, J.W., Kelly, J.A., et al. Identification of unique microRNA signature associated with lupus nephritis. PLoS One, 5, 2010, e10344.
129. [129] Tragante, V., Moore, J.H., Asselbergs, F.W., The ENCODE project and perspectives on pathways. Genet. Epidemiol. 38 (2014), 275–280.
130. [130] Siggens, L., Ekwall, K., Epigenetics, chromatin and genome organization: recent advances from the ENCODE project. J. Intern Med. 276 (2014), 201–214.
131. [131] Qu, H., Fang, X., A brief review on the human encyclopedia of DNA elements (ENCODE) project. Genomics Proteomics Bioinforma. 11 (2013), 135–141.
132. [132] Farnham, P.J., Thematic minireview series on results from the ENCODE Project: integrative global analyses of regulatory regions in the human genome. J. Biol. Chem. 287 (2012), 30885–30887.
133. [133] Dozmorov, M.G., Wren, J.D., Alarcon-Riquelme, M.E., Epigenomic elements enriched in the promoters of autoimmunity susceptibility genes. Epigenetics, 2013, 9.
134. [134] Jeffries, M.A., Dozmorov, M., Tang, Y., Merrill, J.T., Wren, J.D., Sawalha, A.H., Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus. Epigenetics 6 (2011), 593–601.
135. [135] Coit, P., Renauer, P., Jeffries, M.A., Merrill, J.T., McCune, W.J., Maksimowicz-McKinnon, K., et al. Renal involvement in lupus is characterized by unique DNA methylation changes in naive CD4+ T cells. J. Autoimmun. 61 (2015), 29–35.
136. [136] Renauer, P., Coit, P., Jeffries, M.A., Merrill, J.T., McCune, W.J., Maksimowicz-McKinnon, K., et al. DNA methylation patterns in naive CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus. Lupus Sci. Med., 2, 2015, e000101.
137. [137] Chung, S.A., Nititham, J., Elboudwarej, E., Quach, H.L., Taylor, K.E., Barcellos, L.F., et al. Genome-wide assessment of differential DNA methylation associated with autoantibody production in systemic lupus erythematosus. PLoS One, 10, 2015, e0129813.
138. [138] Strickland, F.M., Hewagama, A., Wu, A., Sawalha, A.H., Delaney, C., Hoeltzel, M.F., et al. Diet influences expression of autoimmune-associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus. Arthritis Rheum. 65 (2013), 1872–1881.
139. [139] Reilly, C.M., Thomas, M., Gogal, R. Jr., Olgun, S., Santo, A., Sodhi, R., et al. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. J. Autoimmun. 31 (2008), 123–130.
140. [140] Hofmann-Apitius, M., Alarcon-Riquelme, M.E., Chamberlain, C., McHale, D., Towards the taxonomy of human disease. Nat. Rev. Drug Discov. 14 (2015), 75–76.
141. [141] Krzywinski, M., Schein, J., Birol, I., Connors, J., Gascoyne, R., Horsman, D., et al. Circos: an information aesthetic for comparative genomics. Genome Res. 19 (2009), 1639–1645.
142. [142] Zhou, X.J., Lu, X.L., Nath, S.K., Lv, J.C., Zhu, S.N., Yang, H.Z., et al. Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus. Arthritis Rheum. 64 (2012), 222–231.
143. [143] Shimane K, Kochi Y, Horita T, Ikari K, Amano H, Hirakata M et al. The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. Arthritis Rheum.;62:574–579.
144. [144] Graham, R.R., Cotsapas, C., Davies, L., Hackett, R., Lessard, C.J., Leon, J.M., et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat. Genet. 40 (2008), 1059–1061.
145. [145] Musone, S.L., Taylor, K.E., Lu, T.T., Nititham, J., Ferreira, R.C., Ortmann, W., et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat. Genet. 40 (2008), 1062–1064.
146. [146] Zuo, X.B., Sheng, Y.J., Hu, S.J., Gao, J.P., Li, Y., Tang, H.Y., et al. Variants in TNFSF4, TNFAIP3, TNIP1, BLK, SLC15A4 and UBE2L3 interact to confer risk of systemic lupus erythematosus in Chinese population. Rheumatol. Int. 34 (2014), 459–464.
147. [147] Sheng, Y.J., Gao, J.P., Li, J., Han, J.W., Xu, Q., Hu, W.L., et al. Follow-up study identifies two novel susceptibility loci PRKCB and 8p11.21 for systemic lupus erythematosus. Rheumatol. Oxf. 50 (2011), 682–688.
148. [148] Demirci, F.Y., Wang, X., Kelly, J.A., Morris, D.L., Barmada, M.M., Feingold, E., et al. Identification of a new susceptibility locus for systemic lupus erythematosus on chromosome 12 in individuals of european ancestry. Arthritis Rheumatol. 68 (2016), 174–183.
149. [149] Lewis, M.J., Vyse, S., Shields, A.M., Boeltz, S., Gordon, P.A., Spector, T.D., et al. UBE2L3 polymorphism amplifies NF-kappaB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am. J. Hum. Genet. 96 (2015), 221–234.
150. [150] Wang, S., Adrianto, I., Wiley, G.B., Lessard, C.J., Kelly, J.A., Adler, A.J., et al. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes Immun. 13 (2012), 380–387.
151. [151] Agik, S., Franek, B.S., Kumar, A.A., Kumabe, M., Utset, T.O., Mikolaitis, R.A., et al. The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes. J. Rheumatol. 39 (2012), 73–78.
152. [152] Cunninghame Graham, D.S., Morris, D.L., Bhangale, T.R., Criswell, L.A., Syvanen, A.C., Ronnblom, L., et al. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet., 7, 2011, e1002341.
153. [153] Ciccacci, C., Perricone, C., Ceccarelli, F., Rufini, S., Di Fusco, D., Alessandri, C., et al. A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene. PLoS One, 9, 2014, e111991.
154. [154] Shen, N., Fu, Q., Deng, Y., Qian, X., Zhao, J., Kaufman, K.M., et al. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 15838–15843.
155. [155] Lee-Kirsch, M.A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.A., et al. Mutations in the gene encoding the 3′-5’ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39 (2007), 1065–1067.
156. [156] Namjou, B., Kothari, P.H., Kelly, J.A., Glenn, S.B., Ojwang, J.O., Adler, A., et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun. 12 (2011), 270–279.
157. [157] Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat. Genet. 28 (2001), 313–314.
158. [158] Walport, M.J., Davies, K.A., Botto, M., C1q and systemic lupus erythematosus. Immunobiology 199 (1998), 265–285.
159. [159] Vyse, T.J., Morley, B.J., Bartok, I., Theodoridis, E.L., Davies, K.A., Webster, A.D., et al. The molecular basis of hereditary complement factor I deficiency. J. Clin. Investig. 97 (1996), 925–933.
160. [160] Bowness, P., Davies, K.A., Norsworthy, P.J., Athanassiou, P., Taylor-Wiedeman, J., Borysiewicz, L.K., et al. Hereditary C1q deficiency and systemic lupus erythematosus. Qjm 87 (1994), 455–464.
161. [161] Douglas, K.B., Windels, D.C., Zhao, J., Gadeliya, A.V., Wu, H., Kaufman, K.M., et al. Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. Genes Immun. 10 (2009), 457–469.
162. [162] Wu, H., Boackle, S.A., Hanvivadhanakul, P., Ulgiati, D., Grossman, J.M., Lee, Y., et al. Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 3961–3966.
163. [163] Walport, M.J., Davies, K.A., Morley, B.J., Botto, M., Complement deficiency and autoimmunity. Ann. N. Y. Acad. Sci. 815 (1997), 267–281.
164. [164] Kim, K., Brown, E.E., Choi, C.B., Alarcon-Riquelme, M.E., Kelly, J.A., Glenn, S.B., et al. Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Ann. Rheum. Dis. 71 (2012), 1809–1814.
165. [165] Kim-Howard, X., Sun, C., Molineros, J.E., Maiti, A.K., Chandru, H., Adler, A., et al. Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations. Hum. Mol. Genet. 23 (2014), 1656–1668.
166. [166] Yu, B., Chen, Y., Wu, Q., Li, P., Shao, Y., Zhang, J., et al. The association between single-nucleotide polymorphisms of NCF2 and systemic lupus erythematosus in Chinese mainland population. Clin. Rheumatol. 30 (2011), 521–527.
167. [167] Jacob, C.O., Eisenstein, M., Dinauer, M.C., Ming, W., Liu, Q., John, S., et al. Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), E59–E67.
168. [168] Chang, Y.K., Yang, W., Zhao, M., Mok, C.C., Chan, T.M., Wong, R.W., et al. Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese. Genes Immun. 10 (2009), 414–420.
169. [169] Lu, R., Vidal, G.S., Kelly, J.A., Delgado-Vega, A.M., Howard, X.K., Macwana, S.R., et al. Genetic associations of LYN with systemic lupus erythematosus. Genes Immun. 10 (2009), 397–403.
170. [170] Yang, J., Yang, W., Hirankarn, N., Ye, D.Q., Zhang, Y., Pan, H.F., et al. ELF1 is associated with systemic lupus erythematosus in Asian populations. Hum. Mol. Genet. 20 (2011), 601–607.
171. [171] Manjarrez-Orduno, N., Marasco, E., Chung, S.A., Katz, M.S., Kiridly, J.F., Simpfendorfer, K.R., et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat. Genet. 44 (2012), 1227–1230.
172. [172] Namjou, B., Kim-Howard, X., Sun, C., Adler, A., Chung, S.A., Kaufman, K.M., et al. PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes. PLoS ONE, 8, 2013, e69404.
173. [173] Cunninghame Graham, D.S., Graham, R.R., Manku, H., Wong, A.K., Whittaker, J.C., Gaffney, P.M., et al. Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat. Genet. 40 (2008), 83–89.
174. [174] Delgado-Vega, A.M., Abelson, A.K., Sanchez, E., Witte, T., D'Alfonso, S., Galeazzi, M., et al. Replication of the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosus. Genes Immun. 10 (2009), 248–253.
175. [175] Tan, W., Sunahori, K., Zhao, J., Deng, Y., Kaufman, K.M., Kelly, J.A., et al. Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis Rheum. 63 (2011), 2755–2763.
176. [176] Deng, Y., Zhao, J., Sakurai, D., Sestak, A.L., Osadchiy, V., Langefeld, C.D., et al. Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production. Ann. Rheum. Dis., 2016.
177. [177] Vaughn, S.E., Foley, C., Lu, X., Patel, Z.H., Zoller, E.E., Magnusen, A.F., et al. Lupus risk variants in the PXK locus alter B-cell receptor internalization. Front. Genet., 5, 2014, 450.
178. [178] Oparina, N.Y., Delgado-Vega, A.M., Martinez-Bueno, M., Magro-Checa, C., Fernandez, C., Castro, R.O., et al. PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6. Ann. Rheum. Dis., 74, 2015, e14.
179. [179] Dai, X., James, R.G., Habib, T., Singh, S., Jackson, S., Khim, S., et al. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J. Clin. InvestigInvestig. 123 (2013), 2024–2036.
180. [180] Sakurai, D., Zhao, J., Deng, Y., Kelly, J.A., Brown, E.E., Harley, J.B., et al. Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression. PLoS Genet., 9, 2013, e1003870.
181. [181] Guthridge, J.M., Lu, R., Sun, H., Sun, C., Wiley, G.B., Dominguez, N., et al. Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. Am. J. Hum. Genet. 94 (2014), 586–598.
182. [182] Fu, Q., Zhao, J., Qian, X., Wong, J.L., Kaufman, K.M., Yu, C.Y., et al. Association of a functional IRF7 variant with systemic lupus erythematosus. Arthritis Rheum. 63 (2011), 749–754.
183. [183] Lu, X., Zoller, E.E., Weirauch, M.T., Wu, Z., Namjou, B., Williams, A.H., et al. Lupus risk variant increases pSTAT1 binding and decreases ETS1 expression. Am. J. Hum. Genet. 96 (2015), 731–739.